B. E. YAMASAN Et Al. , "Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy," CARDIOVASCULAR TOXICOLOGY , vol.21, no.8, pp.630-641, 2021
YAMASAN, B. E. Et Al. 2021. Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy. CARDIOVASCULAR TOXICOLOGY , vol.21, no.8 , 630-641.
YAMASAN, B. E., Mercan, T., ERKAN, O., & ÖZDEMİR, S., (2021). Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy. CARDIOVASCULAR TOXICOLOGY , vol.21, no.8, 630-641.
YAMASAN, Bilge Et Al. "Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy," CARDIOVASCULAR TOXICOLOGY , vol.21, no.8, 630-641, 2021
YAMASAN, Bilge E. Et Al. "Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy." CARDIOVASCULAR TOXICOLOGY , vol.21, no.8, pp.630-641, 2021
YAMASAN, B. E. Et Al. (2021) . "Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy." CARDIOVASCULAR TOXICOLOGY , vol.21, no.8, pp.630-641.
@article{article, author={Bilge E. YAMASAN Et Al. }, title={Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy}, journal={CARDIOVASCULAR TOXICOLOGY}, year=2021, pages={630-641} }